Drug · DIN 02487136
VERZENIO
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 3, 2019; first marketed July 3, 2019.
- Drug Identification Number (DIN)
- 02487136
- Company (DIN owner)
- Eli Lilly Canada IncToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Abemaciclib L01EF03
- Class
- Human
- Record last updated
- September 29, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ABEMACICLIB | 200 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 5, 2019: NOC 22040New Drug Submission (NDS)
Other DINs named VERZENIO
- DIN 02487098 · Marketed
- DIN 02487101 · Marketed
- DIN 02487128 · Marketed